Table 2 Comorbidities by participant groups
Comorbidities | Deceased participants | Participants on ventilators | Recovered participants | Total | |
|---|---|---|---|---|---|
Participants | 250 (27,3%) | 151 (16,5%) | 514 (56,2%) | 915 (100,0%) | |
Hypertension | 170 (31,1%) | 83 (15,2%) | 294 (53,7%) | 547 (100%) | |
Diabetes mellitus type 2 | 90 (33,7%) | 32 (12%) | 145 (54,3%) | 267 (100,0%) | |
Cardiovascular diseases | Cardiomyopathy | 42 (35,9%) | 9 (7,7%) | 66 (56,4%) | 117 (100,0%) |
Cardiomyopath/atrial fibrillation | 28 (59,6%) | 4 (8,5%) | 15 (31,9%) | 47 (100,0%) | |
Three/two-vessel coronary disease | 5 (20,0%) | 3 (12,0%) | 17 (68,0%) | 25 (100,0%) | |
AMI/st post MI | 10 (47,6%) | 7 (33,3%) | 4 (19,0%) | 21 (100,0%) | |
Urinary system diseases | Nephropathy | 4 (36,4%) | 2 (18,2%) | 5 (45,5%) | 11 (100,0%) |
Renal insufficiency | 15 (53,6%) | 5 (17,9%) | 8 (28,6%) | 28 (100,0%) | |
Thyroid gland diseases | Hypothyroidism | 9 (21,4%) | 15 (35,7%) | 18 (42,9%) | 42 (100,0%) |
Hyperthyroidism | 3 (30,0%) | 2 (20,0%) | 5 (50,0%) | 10 (100,0%) | |
Other comorbidities | Tumors | 18 (45,0%) | - | 22 (55,0%) | 40 (100,0%) |
Anemia | 10 (40,0%) | 2 (8,0%) | 13 (52,0%) | 25 (100,0%) | |
COPD | 26 (33,3%) | 10 (12,8%) | 42 (53,8%) | 78(100,0%) | |
St post stroke | 14 (53,8%) | 5 (19,2%) | 7 (26,9%) | 26 (100,0%) | |
Obesity | 5 (31,3%) | 4 (16,5%) | 7 (56,2%) | 16 (100,0%) | |